Overall, our gain-of-function (adenovirus-mediated overexpression of KLF2) approach in rat knee joint tissue clearly indicates that KLF2 is a potential therapeutic target for the treatment of osteoarthritis. This evidence concerns the gene KLF2 and osteoarthritis.